{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T02:27:05Z","timestamp":1784773625792,"version":"3.55.0"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2017,2,3]],"date-time":"2017-02-03T00:00:00Z","timestamp":1486080000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2017,11]]},"DOI":"10.1245\/s10434-017-5796-4","type":"journal-article","created":{"date-parts":[[2017,2,3]],"date-time":"2017-02-03T11:11:37Z","timestamp":1486120297000},"page":"3763-3770","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":53,"title":["Clinical Impact of Tumor-Infiltrating Lymphocytes in Esophageal Squamous Cell Carcinoma"],"prefix":"10.1245","volume":"24","author":[{"given":"Tomoya","family":"Sudo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryosuke","family":"Nishida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akihiko","family":"Kawahara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kouhei","family":"Saisho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koshi","family":"Mimori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akira","family":"Yamada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsuhi","family":"Mizoguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazutaka","family":"Kadoya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoru","family":"Matono","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoki","family":"Mori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshiaki","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshito","family":"Akagi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,2,3]]},"reference":[{"key":"5796_CR1","unstructured":"Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A. Global cancer statistics, 2012. CA: Cancer J Clin. 2015;65:87\u2013108. http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/25651787 , https:\/\/www.colwiz.com\/cite-in-google-docs\/cid=colwizBiblio . Accessed 4 Mar 2015."},{"key":"5796_CR2","unstructured":"Lu C-L, Lang H-C, Luo J-C, Liu C-C, Lin H-C, Chang F-Y, et al. Increasing trend of the incidence of esophageal squamous cell carcinoma, but not adenocarcinoma, in Taiwan. Cancer Causes Control CCC. 2010;21:269\u201374. http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/19866363 , https:\/\/www.colwiz.com\/cite-in-google-docs\/cid=colwizBiblio . Accessed 1 Mar 2010."},{"key":"5796_CR3","unstructured":"Tachimori Y, Ozawa S, Numasaki H, Fujishiro M, Matsubara H, Oyama T, et al. Comprehensive registry of esophageal cancer in Japan, 2009. Esophagus. 2016;13:110\u2013137. http:\/\/link.springer.com\/10.1007\/s10388-016-0531-y , https:\/\/www.colwiz.com\/cite-in-google-docs\/cid=colwizBiblio . Accessed 29 Mar 2016."},{"key":"5796_CR4","unstructured":"Robert C, Schachter J, Long GV, Arance A, Grob JJ, Mortier L, et al., KEYNOTE-006 investigators. Pembrolizumab versus ipilimumab in advanced melanoma. New Engl J Med. 2015;372:2521\u201332. http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/25891173 , https:\/\/www.colwiz.com\/cite-in-google-docs\/cid=colwizBiblio . Accessed 25 Jun 2015."},{"key":"5796_CR5","unstructured":"Morgensztern D, Herbst RS. Nivolumab and pembrolizumab for non\u2013small cell lung cancer. Clin Cancer Res Off J Am Assoc Cancer Res. 2016;22:3713\u201317. http:\/\/clincancerres.aacrjournals.org\/cgi\/doi\/10.1158\/1078-0432.CCR-15-2998 , https:\/\/www.colwiz.com\/cite-in-google-docs\/cid=colwizBiblio . Accessed 1 Jun 2016."},{"key":"5796_CR6","unstructured":"Carlo MI, Voss MH, Motzer RJ. Checkpoint inhibitors and other novel immunotherapies for advanced renal cell carcinoma. Nat Rev Urol. 2016;13:420\u201331. http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/27324121 , https:\/\/www.colwiz.com\/cite-in-google-docs\/cid=colwizBiblio . Accessed 21 Jul 2016."},{"key":"5796_CR7","doi-asserted-by":"crossref","unstructured":"Connors JM. Immune checkpoint inhibition: a new era in lymphoma treatment. J Oncol Pract. 2016;12:109\u201310. http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/26869646 , https:\/\/www.colwiz.com\/cite-in-google-docs\/cid=colwizBiblio . Accessed 1 Feb 2016.","DOI":"10.1200\/JOP.2015.009506"},{"key":"5796_CR8","unstructured":"Brahmer J, Reckamp KL, Baas P, Crin\u00f2 L, Eberhardt WEE, Poddubskaya E, et al. Nivolumab versus docetaxel in advanced squamous-cell non\u2013small cell lung cancer. New Engl J Med. 2015;373:123\u201335. http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/26028407 , https:\/\/www.colwiz.com\/cite-in-google-docs\/cid=colwizBiblio . Accessed 9 Jul 2015."},{"key":"5796_CR9","unstructured":"Harrington K, Machiels J-P, Shin SW, Cohen E, Burtness B, Gause C, et al. 13TiP * Pembrolizumab (MK-3475) versus standard treatment in patients with recurrent or metastatic head and neck cancer: methodology of phase 3 randomized trial. Ann Oncol. 2015;26:viii5\u20136. http:\/\/annonc.oxfordjournals.org\/cgi\/doi\/10.1093\/annonc\/mdv514.03 , https:\/\/www.colwiz.com\/cite-in-google-docs\/cid=colwizBiblio . Accessed 18 Nov 2015."},{"key":"5796_CR10","unstructured":"Schneider CA, Rasband WS, Eliceiri KW. NIH Image to ImageJ: 25 years of image analysis. Nat Methods. 2012;9:671\u20135. http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/22930834 , https:\/\/www.colwiz.com\/cite-in-google-docs\/cid=colwizBiblio . Accessed 1 Jul 2012."},{"key":"5796_CR11","unstructured":"Salgado R, Denkert C, Demaria S, Sirtaine N, Klauschen F, Pruneri G, et al., International TILs Working Group 2014. The evaluation of tumor-infiltrating lymphocytes (TILs) in breast cancer: recommendations by International TILs Working Group 2014. Ann Oncol Off J Eur Soc Med Oncol. 2015;26:259\u201371. http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/25214542 , https:\/\/www.colwiz.com\/cite-in-google-docs\/cid=colwizBiblio . Accessed 11 Feb 2015."},{"key":"5796_CR12","unstructured":"Dirican N, Karakaya YA, G\u00fcnes S, Daloglu FT, Dirican A. Association of intratumoral tumor infiltrating lymphocytes and neutrophil-to-lymphocyte ratio are an independent prognostic factor in non\u2013small cell lung cancer. Clin Respir J. 2015. http:\/\/doi.wiley.com\/10.1111\/crj.12417 , https:\/\/www.colwiz.com\/cite-in-google-docs\/cid=colwizBiblio . Accessed 1 Nov 2015."},{"key":"5796_CR13","doi-asserted-by":"crossref","unstructured":"Kim JG, Kang BW, Yoon S. PD-001 * Prognostic value of tumor-infiltrating lymphocytes (TILs) in Epstein-Barr virus (EBV)-associated gastric cancer (EBVaGC). Ann Oncol. 2015;26. http:\/\/annonc.oxfordjournals.org\/cgi\/doi\/10.1093\/annonc\/mdv234.01 , https:\/\/www.colwiz.com\/cite-in-google-docs\/cid=colwizBiblio . Accessed 24 Jun 2015.","DOI":"10.1093\/annonc\/mdv234.01"},{"key":"5796_CR14","unstructured":"Kang BW, Seo AN, Yoon S, Bae HI, Jeon SW, Kwon OK, et al. Prognostic value of tumor-infiltrating lymphocytes in Epstein-Barr virus-associated gastric cancer. Ann Oncol Off J Eur Soc Med Oncol. 2016;27:494\u2013501. http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/26673353 , https:\/\/www.colwiz.com\/cite-in-google-docs\/cid=colwizBiblio . Accessed 16 Mar 2016."},{"key":"5796_CR15","doi-asserted-by":"crossref","unstructured":"Liu K, Yang K, Wu B, Chen H, Chen X, Chen X, et al. Tumor-infiltrating immune cells are associated with prognosis of gastric cancer. Medicine. 2015;94. http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/26426650 , https:\/\/www.colwiz.com\/cite-in-google-docs\/cid=colwizBiblio . Accessed 1 Sep 2015.","DOI":"10.1097\/MD.0000000000001631"},{"key":"5796_CR16","unstructured":"Pruneri G, Gray KP, Vingiani A, Viale G, Curigliano G, Criscitiello C, et al. Tumor-infiltrating lymphocytes (TILs) are a powerful prognostic marker in patients with triple-negative breast cancer enrolled in the IBCSG phase III randomized clinical trial 22-00. Breast Cancer Res Treat. 2016;158:323\u201331. http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/27372069 , https:\/\/www.colwiz.com\/cite-in-google-docs\/cid=colwizBiblio . Accessed 2 Jul 2016."},{"key":"5796_CR17","unstructured":"Ingold Heppner B, Loibl S, Denkert C. Tumor-infiltrating lymphocytes: a promising biomarker in breast cancer. Breast Care. 2016;11:96\u2013100. http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/27239170 , https:\/\/www.colwiz.com\/cite-in-google-docs\/cid=colwizBiblio . Accessed 26 April 2016."},{"key":"5796_CR18","unstructured":"Melichar B, \u0160tudentova H, Kal\u00e1bov\u00e1 H, Vit\u00e1skov\u00e1 D, \u010cerm\u00e1kov\u00e1 P, Hornychov\u00e1 H, et al. Predictive and prognostic significance of tumor-infiltrating lymphocytes in patients with breast cancer treated with neoadjuvant systemic therapy. Anticancer Res. 2014;34:1115\u201325. http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/24596349 , https:\/\/www.colwiz.com\/cite-in-google-docs\/cid=colwizBiblio . Accessed 1 Mar 2014."},{"key":"5796_CR19","doi-asserted-by":"crossref","unstructured":"Issa-Nummer Y, Loibl S, von Minckwitz G, Denkert C. Tumor-infiltrating lymphocytes in breast cancer: a new predictor for responses to therapy. OncoImmunology. 2014;3. http:\/\/www.tandfonline.com\/doi\/abs\/10.4161\/onci.27926 , https:\/\/www.colwiz.com\/cite-in-google-docs\/cid=colwizBiblio . Accessed 1 Mar 2014.","DOI":"10.4161\/onci.27926"},{"key":"5796_CR20","unstructured":"Tsuchikawa T, Md MM, Yamamura Y, Shichinohe T, Hirano S, Kondo S. The immunological impact of neoadjuvant chemotherapy on the tumor microenvironment of esophageal squamous cell carcinoma. Ann Surg Oncol. 2012;19:1713\u20139. http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/21822560 , https:\/\/www.colwiz.com\/cite-in-google-docs\/cid=colwizBiblio . Accessed 6 May 2012."},{"key":"5796_CR21","doi-asserted-by":"crossref","unstructured":"Kim Y, Bae JM, Li G, Cho NY, Kang GH. Image analyzer-based assessment of tumor-infiltrating T cell subsets and their prognostic values in colorectal carcinomas. PloS One. 2015;10. http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/25875774 , https:\/\/www.colwiz.com\/cite-in-google-docs\/cid=colwizBiblio . Accessed 15 Apr 2015.","DOI":"10.1371\/journal.pone.0122183"},{"key":"5796_CR22","unstructured":"Mahmoud SMA, Paish EC, Powe DG, Macmillan RD, Grainge MJ, Lee AHS, et al. Tumor-infiltrating CD8+ lymphocytes predict clinical outcome in breast cancer. J Clin Oncol Off J Am Soc Clin Oncol. 2011;29:1949\u201355. http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/21483002 , https:\/\/www.colwiz.com\/cite-in-google-docs\/cid=colwizBiblio . Accessed 20 May 2011."},{"key":"5796_CR23","unstructured":"Enomoto K, Sho M, Wakatsuki K, Takayama T, Matsumoto S, Nakamura S, et al. Prognostic importance of tumour-infiltrating memory T cells in oesophageal squamous cell carcinoma. Clin Exp Immunol. 2012;168:186\u201391. http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/22471279 , https:\/\/www.colwiz.com\/cite-in-google-docs\/cid=colwizBiblio . Accessed 1 May 2012."},{"key":"5796_CR24","unstructured":"Hatogai K, Kitano S, Fujii S, Kojima T, Daiko H, Nomura S, et al. Comprehensive immunohistochemical analysis of tumor microenvironment immune status in esophageal squamous cell carcinoma. Oncotarget. 2016. http:\/\/www.oncotarget.com\/abstract\/10055 , https:\/\/www.colwiz.com\/cite-in-google-docs\/cid=colwizBiblio . Accessed 15 Jun 2016."},{"key":"5796_CR25","unstructured":"Galon J, Mlecnik B, Bindea G, Angell KH, Berger A, Lagorce C, et al. Towards the introduction of the \u201cImmunoscore\u201d in the classification of malignant tumours. J Pathol. 2014;232:199\u2013209. http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/24122236 , https:\/\/www.colwiz.com\/cite-in-google-docs\/cid=colwizBiblio . Accessed 1 Jan 2014."},{"key":"5796_CR26","unstructured":"Mlecnik B, Bindea G, Angell HK, Maby P, Angelova M, Tougeron D, et al. Integrative analyses of colorectal cancer show immunoscore is a stronger predictor of patient survival than microsatellite instability. immunity. 2016;44:698\u2013711. http:\/\/www.sciencedirect.com\/science\/article\/pii\/S1074761316300644 , https:\/\/www.colwiz.com\/cite-in-google-docs\/cid=colwizBiblio . Accessed 15 Mar 2016."}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1245\/s10434-017-5796-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-017-5796-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-017-5796-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,18]],"date-time":"2019-09-18T03:09:05Z","timestamp":1568776145000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1245\/s10434-017-5796-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2,3]]},"references-count":26,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2017,11]]}},"alternative-id":["5796"],"URL":"https:\/\/doi.org\/10.1245\/s10434-017-5796-4","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,2,3]]}}}